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Abstract  
Primitive hemangiopericytomas of the central nervous system are rare and represent less than 1% of intracranial tumors. Their nonspecific clinical 
and imaging can be misleading and bring to a mistaken diagnosis of meningioma. Radical surgery is the treatment of choice, but must be 
supplemented with postoperative radiotherapy. Hemangiopericytomas have a high potential for recurrence and metastasis. Sellar location is very 
rare and can simulate a pituitary adenoma.We report a case of a 24 year-old woman diagnosed with sellar recurrent HPC without metastasis. 
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Hemangiopericytoma (HPC) is a potentially malignant tumor 
originating from Zimmermann's pericytes around capillaries and 
postcapillary venules [1]. HPCs are located most often, in the 
musculoskeletal system and the skin [2]. Intracranial HPCs are 
uncommon tumors, accounting for less than 1% of primary central 
nervous system (CNS) tumors, and constitute 2% to 4% of 
meningeal tumors [3]. HPC occurred generally on supratentorial 
with most frequency in parasagittal and falcine region mimicking 
meningioma [1]. These tumors have a high potential of recurrence 




Patient and observation 
 
A 24-year-old woman was admitted with a 1-month history of 
headache, and bilateral visual loss. Physicalexamination found no 
neurological deficit, her visual field was 1/10, and bitemporal 
hemianopsia. The other cranial nerves were normal.She had no 
medical pasthistory of hypertension, diabetes mellitus or pulmonary 
tuberculosis.Brain CT scan showed a sellar and supra sellar lesion 
intensely and homogenouslyenhanced by contrast-agent.Brain 
magnetic resonance images (MRI) revealed an intrasellar and 
suprasellar mass with the compression of the chiasm.The lesion was 
isosignal on T1-weighted sequence and slightly hyperintense on T2-
wheighted sequence, with an intense and homogenous 
enhancement (Figure 1 (A). Endocrinological studies showed 
hypopituitarism. The possible diagnosis included pituitary adenoma 
and meningioma. Patient underwent surgery usingtranssphenoidal 
approach. The tumor appears highly vascularized accommodated a 
subtotal resection (Figure 1 (B). Histologicaldiagnosis was 
hemangiopericytoma (Figure 2). She received a local radiotherapy 
(52 Gy) of the pituitary fossa. Two years later, she complained of 
headaches and visual loss. Brain MRI showed a contrast-enhancing 
soft tissue mass arising from the pituitary fossa (Figure 3). Partial 
resection of the tumor was done and pathologic findings were 
compatible with hemangiopericytoma. Thoracoabdominal CT 
scanwas normal. The patient received a second radiotherapy with 
favorable outcome after one year follow-up, without recurrence of 





Intracranial HPCs are uncommon tumors, accounting for less than 
1% of primary CNS tumors, and constitute 2-4% of meningeal 
tumors [3]. They were previously classified as angioblastic sub-type 
meningiomas [5]. Since 1993, HPCs are classified in the group of 
“mesenchymal, non-meningothelial tumors” [6]. These tumors arise 
from smooth muscle perivascular pericytes of Zimmerman.They are 
more aggressive than meningiomas, with high frequency of 
recurrence and metastasis [4]. HPCs are commonly located 
insupratentorial region (parasagittal or falcine) [1]. Sellar location is 
very rare. Few cases have been reported in the literature [1,4,7]. It 
occurs on male patients in 55% to 77% from 38 to 42 years [1]. In 
our case the patient was a young woman of24 years old. 
  
Brain imaging (CT and MRI) are important but couldn't make a 
difference with meningioma [7-9]. However, some elements could 
help to make a difference between HPC and meningioma. 
Intratumoral calcification or hyperostosis reaction in contact with 
the insertion zone are never viewed in HPCs; bone destruction 
without piping osteosclerosis is a classic look, but nonspecific. The 
edges are often irregular and polylobed. Contrast enhancement 
after injection is often intense and heterogeneous [7,8]. In sellar 
locations, diagnostic of pituitary macroadenoma is most often 
carried, and transsphenoïdal approach is proposed. The treatment 
of primitive HPCscentral nervous system based on complete 
resection of the tumor, followed by radiation in order to prevent 
recurrence and metastasis [8-10]. Immunohistochemistry can 
differentiate HPC from meningioma: HPC stains positive for CD 34, 
factor VIII, and vimentin but negative for S-100 and epithelial 
membrane antigen (EMA) [3,11]. 
  
HPCs can recur locally or distantly in the neural axis or metastasize 
to extraneural sites [12]. Schiariti reported 28 cases of local 
recurrence, in a series of 39 patients. The recurrence rate at 1, 5, 
and 15 years was 3.5%, 46%, and 92%, respectively. Extraneural 
metastasis occurred in 8 patients (26%) at an average of 123 
months after initial surgery [12]. In our case the recurrence appears 
after two years. According to Myung-Hwan [1], it is after 9 
years.Recurrence is a late event in the natural history of HPC. Close 
follow-up for a long period after the first surgery is needed. 
Complete excision favorably affects recurrence and survival, as 
opposed to incomplete excision [13]. Because the hypervascular 
characteristics of HPC simply “radiosensitivity”, postoperative 
adjuvant radiotherapy appears to significantly decrease the local 
recurrence rate and lengthen recurrence-free duration. However 
recurrence remains a common treatment outcome regardless of 
initial strategy [13]. Stereotactic radiosurgery is benefic in case of 
recurrent HPCs [14]. Extended analysis using lesion data available 
revealed that higher marginal dose (≥ 17 Gy) was also significant (P 
= 0.028). Kim and al., reported that Gamma Knife Stereostatic 
Radiosurgery provides an effective and safe adjuvant management 
option for patients with recurrent or residual HPCs [14]. The local 
tumor recurrence in our case could be assigned to incomplete 





Sellar and suprasellar HPC can mimic a pituitary tumor.This case 
illustrates a difficulty to establish diagnostic on imaging and clinical 
exams. Diagnosis is made byhistological studies. Unfortunately HCP 
has usually poor prognosis. Although rare in sellar location, HCP 
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Figure 1: (A): Preoperative magnetic resonance image showing a 
sellar and suprasellar solid mass; (B): postoperative magnetic 
resonance image showing a remnant  
Figure 2: Histology of tumor, immunohistochemical staining 
revealing positive reaction for CD 34  
Figure 3: Recurrent tumor arising from the pituitary fossa  
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Figure 1: (A): Preoperative magnetic resonance image showing a sellar and suprasellar solid mass; 
(B): postoperative magnetic resonance image showing a remnant  
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Figure 2: Histology of tumor, immunohistochemical staining 










Figure 4: MRI one year after second surgery and radiotherapy 
 
 
